Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics of Venlafaxine and Fluoxetine in MDD
NCT01204086Phase 4Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Mar 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine, fluoxetine in major depressive disorder (MDD), sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
venlafaxinefluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01204086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204086.